Hormonal control of transepithelial sodium (Na ؉ ) transport utilizes phosphatidylinositide 3-kinase (PI3K) and Raf-MAPK/ERK kinase (MEK)-ERK-dependent signaling pathways, which impact numerous cell functions. How signals transmitted by these pathways are sorted and appropriately transmitted to alter Na ؉ transport without altering other physiologic processes is not well understood. Here, we report the identification of a signaling complex that selectively modulates the cell surface expression of the epithelial sodium channel (ENaC), an ion channel that is essential for fluid and electrolyte balance in mammals. Raf-1 and the ubiquitin ligase, Nedd4-2, are constitutively-expressed inhibitory components of this ENaC regulatory complex, which interact with, and decrease the expression of, cell surface ENaC. The activities of Nedd4-2 and Raf-1 are inhibited cooperatively by the PI3K-dependent kinase serum-and glucocorticoid-induced kinase 1 (SGK1), and the Raf-1-interacting protein glucocorticoid-induced leucine zipper (GILZ1), which are aldosterone-stimulated components of the complex. Together, SGK1 and GILZ1 synergistically stimulate ENaC cell surface expression. Interestingly, GILZ1 and SGK1 do not have synergistic, and in fact have opposite, effects on an unrelated activity, FKHRL1-driven gene transcription. Together, these data suggest that GILZ1 and SGK1 provide a physical and functional link between the PI3K-and Raf-1-dependent signaling modules and represent a unique mechanism for specifically controlling Na ؉ transport without inappropriately activating other cell functions.
T he hormonal control of ion transport in the kidney tubules is essential for physiological regulation of electrolyte concentrations and blood pressure in vertebrates. Recent evidence has established that this regulation involves modulation of pleiotropic signaling pathways, which impact numerous cell functions, and how these signals are sorted and appropriately transmitted to mediate context-specific effects such as ion transporter regulation is not well established.
The epithelial sodium channel (ENaC), which constitutes the rate-limiting step in transepithelial sodium (Na ϩ ) transport in the principal hormone-regulated segment of the renal tubule, is a key target for hormone regulation. Disorders of ENaC expression or regulation result in severe disease phenotypes in humans (1, 2) . Two pleiotropic signaling pathways are implicated in regulating ENaC trafficking and activity: phosphatidylinositide 3Ј-kinase (PI3K)-dependent signals stimulate the AGC family kinase serum-and glucocorticoid-induced kinase 1 (SGK1), which phosphorylates and inhibits the HECT-domain ubiquitin ligase Nedd4-2; Nedd4-2 in turn physically interacts with and ubiquitinates the channel, reducing its recycling to the plasma membrane and stimulating its internalization and degradation (1, 3, 4) . It is interesting to note that the PI3K pathway, and SGK1, in particular, affect a variety of other signaling molecules and transcription factors to markedly influence distinct cellular processes such as proliferation, apoptosis, and glucose metabolism. SGK1 exerts antiapoptotic effects by phosphorylating and inhibiting the proapoptotic transcription factor FKHRL1 (also called FOXO3) (5) .
A parallel and apparently distinct signaling cascade, the Raf-1-MAPK/ERK kinase (MEK)1/2-ERK1/2 (Raf-MEK-ERK) pathway, however, acts to inhibit cell surface ENaC through ERK1/2-dependent phosphorylation of the channel itself, which stimulates its interaction with Nedd4 (6) (7) (8) (9) . Recent evidence supports the idea that the Raf-interacting protein glucocorticoid-induced leucine zipper protein 1 (GILZ1) increases plasma membrane ENaC in part by antagonizing the inhibitory effect of the Raf-MEK-ERK module (10, 11) .
There have been hints that the PI3K and Raf-MEK-ERK pathways intersect in the control of ENaC (12, 13) . Although SGK1 and GILZ1 have been shown to disinhibit each inhibitory pathway separately (13) , recent observations reveal that ENaC phosphorylated by activated ERK exhibits enhanced interaction with Nedd4-1 and subsequent internalization and degradation (14) . Nedd4-1 is a close relative of Nedd4-2 with WW domains that bind ENaC similarly (14) . Studies also indicate that PKC activation of the ERK1/2 cascade leads to targeted degradation of ENaC (15) . PKC signaling impinges on the ERK1/2 cascade by activating Raf-1 (16) .
The expression of both SGK1 and GILZ1 is coordinately stimulated at the transcriptional level by aldosterone. This observation, together with data suggesting that PI3K-and Raf-MEK-ERK-dependent signaling might functionally interact in the regulation of ENaC, led to the speculation that these inhibitory and stimulatory factors might be assembled in a regulatory complex, which has cooperative effects on the channel. Such cooperative effects within a channel-associated signaling complex would provide a potential mechanism for achieving selective ion transport regulation through the PI3K and Raf-MEK-ERK signaling pathways. The present findings support such a mechanism. Indeed, our data support the existence of a novel ENaC regulatory complex, which includes Nedd4-2 and Raf-1. GILZ1 physically interacts with and inhibits this complex and recruits SGK1 to it. This effect of GILZ1 appears to contribute to the specificity of the Raf-MEK-ERK and PI3K signaling pathways.
reasons for using this cell line for our analyses were manifold: these mammalian kidney epithelial cells reliably express and traffic to the plasma membrane a variety of integral membrane proteins, including ion transporters and channels (17, 18) . The use of EGF to activate ERK1/2 in these cells through stimulation of endogenous EGF receptor is well described (19, 20) , and we have shown that activated ERK1/2 inhibits surface ENaC and GILZ1 reverses this process (10) . Hence HEK 293T cells offered a useful system for examining regulatory factors that potentially govern ENaC surface expression.
We first examined associations of Raf-1 and Nedd4-2 with ENaC, mimicking the basal state in the kidney tubules in which GILZ1 and SGK1 levels are low. We found evidence for association of Nedd4-2 ( Fig. 1 A) and Raf-1 (Fig. 1B) with ENaC (␤-subunit) and with each other (Fig. 2A) . Furthermore, by indirect confocal immunofluorescence microscopy, we observed strong colocalization of HA-mRaf-1 and FLAG-mNedd4-2 (see Fig. S1 A), consistent with the co-IP results. The interactions of Raf-1 with both Nedd4-2 and ENaC are novel findings, which taken together with the well-established interaction of Nedd4-2 with ENaC (21), suggests the existence of an inhibitory complex. We next examined the interactions of GILZ1 and SGK1 with Raf-1 and Nedd4-2 and with ENaC itself by using co-IP assays. As shown (10, 11), Raf-1 was detected in GILZ1 immunoprecipitates (Fig. 2 A) and, interestingly, Nedd4-2 (Fig. 2B) , and ␤-ENaC (Fig. 2 A and B) were detected as well (shown graphically in Fig. 2C ). These interactions were largely unaffected by SGK1 (Fig. 2 A, compare lanes 2 and 4, and Fig. 2B , compare lanes 2 and 4). In contrast, the interaction of SGK1 with both Nedd4-2 and Raf-1 was markedly stimulated by GILZ1 (Fig. 2  A and B) , which is depicted graphically in Fig. 2D (Left, SGK1-Nedd4-2; Right, SGK1-Raf-1). Finally, co-IP data also strongly supported a physical interaction between GILZ1 and SGK1 ( Fig. 2 A and B) . Together, these data support the conclusion that Nedd4-2 and Raf-1 are stably associated in a complex that interacts with ENaC, and further, that GILZ1 physically interacts with this complex and recruits SGK1 into it. Consistent with the co-IP data, Raf-1 and Nedd4-2 were strongly colocalized even in the absence of GILZ1 and/or SGK1 (see Fig.  S1 A). GILZ1 was strongly colocalized with both Raf-1 (Fig. S1B ) and Nedd4-2 ( Fig. S1C ) in transfected HEK 293T cells, and it strongly stimulated the localization of SGK1, to an overlapping subcellular compartment (Fig. S1 ). We propose that this compartment, which does not colocalize with plasma membrane markers, represents a site of regulated ENaC trafficking. However, further experiments will be needed to determine whether this compartment contains ENaC and corresponds to the site in which the physical interactions are detected.
Recent work has identified multiple isoforms of GILZ and demonstrated that GILZ1 is the isoform that most potently stimulates ENaC (22) . Consistent with these results, GILZ1, but not GILZ2 or GILZ4, interacted strongly with ␤-ENaC, Raf-1, Nedd4-2, and SGK1 (see Fig. S2 ). Interestingly, the proteins that do not interact with components of the ENaC regulatory complex, GILZ4 and ⌬40-GILZ1 (an artificial construct), both lack the N terminus. These data further suggest that the GILZ1 N-terminal domain is required for its recruitment into the complex.
GILZ1 and SGK1 Cooperatively Inhibit Raf-1 and Nedd4-2 Activities.
Next, we wanted to begin to explore the functional significance of this protein complex and, in particular, examine the effects of GILZ1 and SGK1 alone and together in inhibiting Raf-1 kinase activity and Nedd4-2 ubiquitin ligase activity. As demonstrated (11), GILZ1 strongly inhibited Raf-1 kinase activity (Fig. 3A) . SGK1 also had a moderate inhibitory effect (Fig. 3A) , consistent with earlier reports demonstrating SGK1 inhibition of B-Raf (23), which has similar SGK1 consensus substrate sequences. Notably, however, inhibition was markedly greater when GILZ1 and SGK1 were both expressed, consistent with the idea that they act cooperatively to inhibit Raf-1. Similar cooperative effects were seen on Nedd4-2-dependent ubiquitin ligase activity when using ENaC as substrate ( Fig. 3B ): ENaC (␣-subunit) was heavily ubiquitinated in a Nedd4-2-dependent fashion, and SGK1 had a substantial inhibitory effect, as has been shown (24, 25) . We also observed modest but consistent inhibition of Nedd4-2 by GILZ1 alone (Fig. 3B, lane 4) ; however, the inhibition was markedly greater when both GILZ1 and SGK1 were expressed. Together, these data suggest that SGK1 and GILZ1 act cooperatively to inhibit Raf-1 and Nedd4-2 activities.
GILZ1 and SGK1 Synergistically Stimulate ENaC Cell Surface Expres-
sion. So far, we observed that GILZ1 enhances the interaction of SGK1 with Nedd4-2 and Raf-1, and that the two synergize in inhibiting Nedd4-2 ubiquitin ligase activity and Raf-1 kinase activity. To examine the effects of these regulators on ENaC cell surface expression, we used surface biotinylation assays to capture plasma membrane ENaC in HEK 293T kidney epithelial A B cells. Consistent with earlier results (10, 26, 27) , we found that at high levels of expression SGK1 and GILZ1 each separately stimulated cell surface ENaC density ( Fig. 3 C and D) ; however, there was marked synergy between them, and importantly, the concentration of SGK1 required to achieve comparable ENaC cell surface expression was markedly reduced in the presence of GILZ1 ( Fig. 3 C and D, compare lanes 2-4 with lanes 8-10). Thus, we conclude that GILZ1 and SGK1 act cooperatively to enhance ENaC cell surface expression. There was also a consistent moderate stimulatory effect of GILZ1 and SGK1 on total cellular ENaC expression, which likely ref lects decreased degradation.
GILZ1 Effects on SGK1 Are Selective. Next, we asked whether the cooperative functional effects of GILZ1 and SGK1 are generalized or demonstrate specificity. We therefore examined a well-characterized unrelated action of SGK1, which is to inhibit gene transcription mediated by the proapoptotic mammalian forkhead homologue, FOXO3 (5) . HEK 293T cells were cotransfected with a forkhead reporter gene [FHRE-Luc, harboring a consensus forkhead response element (FHRE) driving luciferase gene expression], and SGK1 or GILZ1, or both together. As reported (5), SGK1 inhibited FOXO3-dependent gene transcription (Fig. 3E) ; however, GILZ1 did not augment the SGK1 effect, but rather it mildly stimulated FOXO3- dependent transcription, and GILZ1 and SGK1 together had no effect relative to basal activity. These results strongly support the conclusion that the synergistic effects of GILZ1 and SGK1 on ENaC are specific.
Evidence for the Existence of an Endogenous EnaC Regulatory Complex in Polarized Kidney Epithelial Cells. Finally, we wanted to determine whether these interactions indeed occur among endogenous proteins in kidney collecting duct cells and how aldosterone might regulate them. We performed a series of co-IP experiments (Fig. 4 ) using lysates prepared from polarized mpkCCD c14 cells grown to confluence on Transwell filters and treated with aldosterone. We were able to visualize key interactions of these ENaC-regulatory proteins. We observed that Raf-1 and Nedd4-2 were indeed associated in a complex, and their interaction was moderately, but consistently, enhanced upon aldosterone treatment (Fig. 4) . GILZ also specifically interacted with Raf-1 and Nedd4-2, and again, these interactions were enhanced by aldosterone (Fig. 4) . We also observed that GILZ interacted with ␣ENaC (Fig. 4) . Interestingly, the interaction was more pronounced with the Ϸ65-kDa processed form of ␣ENaC. Finally, ␤ENaC was also coimmunoprecipitated by GILZ, which also was modestly increased by aldosterone (Fig. 4) .
The above data confirm the existence of these specific components of the ENaC regulatory complex in polarized kidney collecting duct cells and merit further investigation to verify the other components and the regulation of the complex.
A Mechanism for SGK1 Specificity. SGK1 has been implicated in regulating many cellular functions in a PI3K-dependent fashion, including epithelial Na ϩ transport, proliferation, apoptosis, and metabolism (2). To date, it has not been well understood how SGK1 deploys its broad spectrum of effects appropriately in specific contexts. Our data suggest that Raf-1 and Nedd4-2 are associated with each other in an ENaC regulatory complex, which in the absence of aldosterone, when GILZ1 and SGK1 levels are low, interacts with and ubiquitinates ENaC, thus stimulating net internalization and degradation ( Fig. 3 B and C) . Aldosterone increases GILZ1 and SGK1 expression through effects on their gene transcription (10) , and as the expression of both proteins rises GILZ1 is strongly recruited into the complex through physical interactions with Raf-1 and Nedd4-2, and it in turn recruits SGK1. Consistent with this idea, GILZ1 both enhanced the co-IP of SGK1 with Raf-1 and Nedd4-2 ( Fig. 2 A,  B, and D) , and markedly increased their subcellular colocalization (Fig. S1 B and C) . This latter effect was caused by relocal- ization of SGK1 and was not reciprocal: SGK1 had no effect on GILZ1 localization or interaction with the complex. Once in the complex, SGK1 and GILZ1 act cooperatively to inhibit the negative regulators Nedd4-2 and Raf-1 ( Fig. 3 A and B) , thereby reducing ENaC internalization and degradation ( Fig. 3 C and D) . We also demonstrate that upon aldosterone treatment in polarized mpkCCD c14 kidney epithelial cells (a state where expression levels of both SGK1 and GILZ1 are up-regulated), there is enhanced interaction of Raf-1 and Nedd4-2 (Fig. 4) . We also observed enhanced interaction of GILZ1 with ␣-and ␤-ENaC, Nedd4-2, and Raf-1 upon aldosterone treatment (Fig. 4) . This association of PI3K and Raf-1 pathway components into an ion transport regulatory complex provides a novel mechanism for achieving signaling specificity (9, 10, (28) (29) (30) (31) . Through this mechanism, ion transport can be selectively stimulated while having little or no effect on context-inappropriate targets. In this regard, it is notable that GILZ1 and SGK1 have opposing effects on forkhead-regulated gene transcription (Fig. 3E) , in striking contrast to their synergistic effects on ENaC, Raf-1, and Nedd4-2. Forkhead is a potent proapoptotic factor (5), and these differential actions may allow GILZ1 and SGK1 to stimulate ENaC without impacting on apoptosis or other cellular processes.
These observations, with exogenously-expressed proteins in 293T cells and endogenous proteins in polarized mpkCCD c14 kidney epithelial cells, provide a key step in identifying a novel specific role for GILZ1 for orchestrating and regulating events within an ENaC regulatory complex. These data further suggest that GILZ1 acts as a scaffolding protein, interacting with and promoting interactions among a group of proteins, which have in common their interactions, direct or indirect, with GILZ. We term these proteins GILZ-interacting proteins (GILZIPs). Further studies will be needed in the context of endogenous proteins and in whole animals to determine the full physiological relevance of the GILZIPs and the ENaC regulatory complex and the precise mechanisms underlying its actions in vivo.
Multiple translation and phosphorylation products have been described for SGK1. In particular, it is interesting to recall recent studies that showed the existence of 4 independent SGK1 products that arise because of use of alternate start sites during translation (32) . Interestingly, we observed that although 4 separate SGK1 variants are consistently expressed in total cellular lysates (Fig. 2 A and B, SGK1 expression) , only one of these (the longer product) is selectively and consistently recruited into the complex (Fig. 2 A and B, IP-HA) . The effect of GILZ1 seems to be selectively on the longer SGK1 product that presumably has the N terminus intact. In this context, it is pertinent to recall earlier studies from our laboratory and others that showed that the N terminus of SGK1 is important for its ENaC-stimulatory activities via Nedd4-2 inhibition (5, 32) . Further studies will be needed to elucidate the role of the N terminus and PY motif of SGK1 in the context of the ENaC regulatory complex.
We show the existence of an ENaC-Raf-1-Nedd4-2 complex. The functional significance of these observations is profound. In the kidney, ERK1/2 is expressed in all nephron segments and plays an important role in multiple physiological (33) and pathological processes (30) . In contrast to other nephron segments, ERK1/2 appears to have basal activity in distal nephron cells (31, 34) , consistent with tonic inhibition of Na ϩ transport by the ERK pathway. It is well demonstrated that the components of the MAPK cascade (Raf-1, MEK1/2, and ERK1/2, in this case) exist in a multiprotein complex to permit the cell to perform coordinate regulation of several simultaneous possibly divergent signals at multiple levels (35) . The present report suggests the involvement of Nedd4-2 in this complex as well. Together, these observations are consistent with the hypothesis that tonic ENaC inhibition by ERK1/2 and Nedd4-2 is implicated in setting baseline Na ϩ transport, and that aldosterone stimulates Na ϩ transport in part by increasing GILZ1 expression, which inhibits ERK1/2 signaling on the one hand, and on the other, acts in concert with aldosterone-induced SGK1 to specifically enhance ENaC-mediated Na ϩ current.
Experimental Methods
All experiments have been performed at least 3 independent times with similar results. For more details about methods used see SI Text.
Co-IP Assays. HEK 293T cells were transfected with appropriate expression vectors (as shown in the figures) using lipofectamine according to the manufacturer's instructions (Invitrogen) as described (22) . After 48 h of transfection, cells were treated with 100 ng/mL EGF for 1 h, and cell lysates were harvested for protein analysis. mpkCCDc14 cells were maintained and grown on Transwell filters as described (22) . After 4 h of aldosterone treatment (10 Ϫ6 M), cells were harvested and processed for protein analysis.
IPs were performed using protein A or G agarose beads (Santa Cruz Biotechnology) and anti-GILZ antibody (22) , anti-Raf-1 antibody (BD Transduction Labs), immobilized anti-Flag (Sigma) or anti-HA (Roche Applied Science) beads, and immunoblotted using our anti-GILZ antibody (22) , anti-Flag-HRP antibody (Sigma), anti-HA-HRP antibody (Roche), anti-Nedd4 antibody (Upstate Biotechnology), anti-V5-HRP antibody (Invitrogen), anti-Nedd4-2 antibody (Abcam), anti-␣ENaC antibody (Santa Cruz Biotechnology), anti-␤ENaC antibody (gift from Mark Knepper, National Institutes of Health, Bethesda), and anti-Raf-1 antibody. Total GAPDH or ␣-tubulin was used as a loading control. For densitometric analyses, signal intensities of specified bands were determined by using National Institutes of Health ImageJ software and normalized to that of the internal control. Values so obtained were used to determine mean Ϯ SEM for a graphical representation.
Raf-1 Kinase Activity Assays. HEK 293T cells were cotransfected with appropriate expression vectors as specified in the figures. Forty-eight hours after transfection, cells were treated with 100 ng/mL EGF for 1 h and harvested for Fig. 4 . Evidence for an endogenous complex composed of ENaC-regulatory proteins. Co-IP assays were performed using lysates from polarized mpkCCD c14 kidney epithelial cells that were treated with aldosterone (Aldo, 1 M) or vehicle for 4 h. Immunoblots (IB) demonstrating total cellular expression of the various proteins specified are also shown. ␣-Tubulin was used as a loading control. WCL, whole-cell lysate.
protein analysis. Lysates were subjected to IP for Raf-1 by using protein-A agarose beads (Santa Cruz Biotechnology) and a highly-specific anti-Raf-1 antibody (Cell Signaling). Raf-1 immunoprecipitates were then analyzed for kinase activity by using [ 32 P]-labeled ATP and commercially-available substrates according to the manufacturer's instructions (Upstate).
Ubiquitination Assays. Ubiquitination assays were performed as described (24) in HEK 293T cells. Cotransfections were performed as specified in the figures. Forty-eight hours after transfection, cells were treated with 100 ng/mL EGF for 1 h and harvested appropriately. Lysates were subjected to IP using anti-HA antibody to selectively recover ␣-ENaC. Immunoprecipitates were analyzed by Western blot analysis using a monoclonal anti-ubiquitin antibody (Covance).
Cell Surface Biotinylation Assays. HEK 293T cells were cotransfected as specified in the figures. Forty-eight hours after transfection, cells were treated with 100 ng/mL EGF for 1 h followed by treatment with EZ-Link Sulfo-NHS-Biotin (Pierce) for 1 h before extraction and recovery of biotinylated proteins with immobilized neutravidin beads (Thermo Scientific).
Immunoprecipitates were analyzed for cell surface (biotinylated) ␣-ENaC by immunoblotting using anti-HA antibody. As a control for integrity of cells during the biotinylation process, the blot was stripped and reprobed for GAPDH. Total GAPDH was used as a loading control. Densitometric analyses were performed with National Institutes of Health ImageJ software as described above.
FHRE-Luciferase Reporter Assays. HEK 293T cells were cotransfected as specified in the figures along with a reporter vector (FHRE-LUC) containing a FKHRL1-binding site in which the promoter drives the expression of the firefly luciferase (gift from M. Greenberg, Harvard Medical School, Boston) and the constitutively-transcribed RSV-␤-galactosidase plasmid, ⌬6RL [which serves as an internal control for transfection efficiency (36) ]. Fortyeight hours after transfection, cell lysates were harvested and processed to assess protein content, luciferase activity, and ␤-galactosidase activity as described (22, 36) . [Note: Here we were assaying for endogenous Forkhead activity in HEK 293T cells; these cells are known to have FKHRL1 or the FOXO3a protein (5) .] Statistical Analyses. Data are represented as mean Ϯ SEM. In all experiments involving statistical analyses, 3-6 samples were tested, and at least 3 independent experiments were performed with the same treatment protocol. Unless otherwise specified, all statistical comparisons were evaluated by using Student's unpaired 2-tailed t test, and significance was defined as P Ͻ 0.05.
